PSO 2010 Conference Update

PSO 2010 Update

We had an excellent conference, collecting contact details from 218 physicians who were interested in our product. To sum it up, the attendees from a big pharma competitor stationed across from us were so impressed by our traffic that they approached us after the conference and wanted to find out more about who we were and what our product was. It may be a a double-edged sword, but the competiton is already taking notice!

Truly, though, it is clear that what we have (an oral TNFa inhibitor) is really a holy-grail type product for this condition. Of course, we aren't going to wait passively for the physician community to accept our results. We are going to push our message to all the relevant constituencies, including thought-leader physicians, patient advocates and natural health proponents.

A couple of key highlights we took away:

-the biologics have serious side effects, and they are not seen as a final answer by any stretch

-emerging markets should be an early opportunity as they simply can't afford biologics

-Germany is very favorable to herbals; we already have 3 department heads who want to do pilot studies in Germany

-clear, concise scientific explanation should convince early adopter physicians and sophisticated patients that this Tinefcon is worth trying

Tinefcon Team at San Francisco Walk for a Cure

The Tinefcon team sponsored the Walk to Cure Psoriasis in San Francisco on June 26. About 400 volunteers and supporters participated on what was one of the most beautiful days I can remember in the city by the bay.

We donated $2,500 plus t-shirts and free supplies of tinefcon for the raffle. Six members of our team also participated in the 6k walk.

In addition to meeting many interesting people and enjoying the good weather, the Walk was a positive experience otherwise: we learned a lot about our potential customers.

I spoke with one volunteer who told me he had lost a lung due to a fungal infection brought on by use of a biologic treatment. Scary! I met another women whose insurance company was reducing her benefits towards Enbrel, meaning she could no longer afford treatment. And we met several people who told us their doctors would not prescribe them biologics for fear of the side effects.

Everyone was intrigued by the potential of Tinefcon, and we gave out a couple of three month trial samples to some lucky raffle winners. This is the first of many events we expect to host with the National Psoriasis Foundation, so keep checking our website to find out when we will next be near to you.